Our mission is to discover drugs for high unmet medical needs that will improve quality of life for patients with Orphan Diseases.
We stand out by our ability to deliver high value products with relatively little cost in a short period of time. Due to our business model we reduce the risk of drug development.
SOM Biotech has a strong pipeline of products focused on Orphan diseases at preclinical and clinical stages.
NEWS & PRESS RELEASES
SOM Biotech aims to strengthen its communication and investor relations strategy with the support of Maqua Capital
As an essential part of SOM Biotech´s strategy to strengthen its visibility within the investment […]
SOM Biotech attended 3rd “Hard Reg Café” meeting dedicated to the topic of FDA approval for new drugs
Dr. Maria Zimina, Business Development Manager at SOM Biotech, attended “Hard Reg Café” of Regulatory […]
SOM Biotech collaborated in the organization of the University of Barcelona Summer Course about Rare Diseases
SOM Biotech collaborated in the organization of the University of Barcelona Summer Course: “Rare Diseases: […]
SOM Biotech participated at Barcelona Biotech Breakfast: Applying Artificial Intelligence in Drug Discovery and Development
Oscar Huertas, Drug Discovery Manager, and Maria Zimina, Business Development Manager of SOM Biotech, participated […]
SOM Biotech at Veeva R&D Summit Europe 2019
Dr. Raúl Insa, SOM Biotech CEO, participated in the Clinical Roundtable at Veeva R&D Summit […]
SOM Biotech at BIO 2019
SOM Biotech attended the BIO International Convention in Philadelphia last 3-6 June 2019. BIO is […]
SOM Biotech at the International Congress 2019 on Duchenne Muscular Dystrophy and Becker
Dr. Raúl Insa, SOM Biotech CEO, gave a talk on the topic “Repositioning of Utrophin” […]
Interview of SOM Biotech for Labiotech.eu
Dr. Raúl Insa, SOM Biotech CEO, gave an interview to Labiotech.eu, leading digital media covering […]
SOM Biotech will attend the 12th Annual Global Discovery to Development Innovation Forum (GDDIF)
Dr. Luca Signorile, Senior computational chemist at SOM Biotech, will be attending the 12th Annual […]
SOM Biotech at TechShare – pre-IPO programme launched by Euronext
Dr. Raúl Insa, SOM Biotech CEO, attended the second campus of the 2018-2019 TechShare programme organized by Euronext and Nova […]